Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-18-008700)

Filing Details

Accession Number:: 0000899243-18-008700
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-28 16:08:44
Reporting Period:: 2018-03-26

Accepted Time:: 2018-03-28 16:08:44
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	Pharmaceutical Preparations (2834)	455500552

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654909	Jake Bauer	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-26	164	$9.08	61,941	No	4	M	Direct
Common Stock	Disposition	2018-03-26	164	$50.95	61,777	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-03-26	164	$0.00	164	$9.08

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,748		2026-02-01	No	4	M	Direct

Footnotes

This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020.